EANS-Adhoc: Semperit AG Holding / Successful Start in 2014 (with photo)

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

Financial Figures/Balance Sheet/quarterly report
20.05.2014

* Revenue up 8.1% in Q1 2014 to EUR 232.7 million
* Significant rise in EBITDA (+14.0%) and EBIT (+18.9%)
* Growth and enhanced profitability in both sectors
* Continuation of the good order situation expected

Vienna, May 20, 2014 - The publicly listed Semperit Group recorded
the best first-quarter result in the company's history during the
first three months of 2014, achieving significant increases in
revenue and earnings. Revenue in the first quarter of 2014 rose 8.1%
year-on-year to EUR 232.7 million from EUR 215.2 million in the
prior-year period. Both Medical and Industrial Sectors contributed to
growth based on strong sales performances and higher global sales.
The Medical Sector once again expanded faster than the market. The
more cyclically-dependent Industrial Sector succeeded in further
increasing revenue and profitability.

In the first quarter of 2014, the Group's consolidated EBITDA
improved by 14.0% to EUR 33.4 million from EUR 29.3 million in the
previous year. EBIT climbed by 18.9% to EUR 22.3 million compared to
the prior-year level of EUR 18.8 million. In addition to the strong
operating development, the resolute implementation of strategic raw
material management, stringent cost discipline and further efficiency
improvements contributed to the rise in earnings. The EBITDA margin
was up from 13.6% to 14.4%, and the EBIT margin climbed to 9.6% from
8.7% in the previous year. Semperit achieved a net result (earnings
after tax) of EUR 13.1 million, constituting an increase of 5.0% from
the comparable level of EUR 12.5 million in the first quarter of
2013.

"We grew faster than the market in the first quarter of 2014 because
we succeeded in massively strengthening and further
internationalising our sales activities. We expanded our product
portfolio by adding new products which have been successful in the
marketplace, and intensified our customer service. We are attracting
new key accounts and further expanding the business with our existing
customers", says Semperit CEO Thomas Fahnemann in assessing the
current business development. "With respect to costs, we are
profiting from the active management of our raw material needs as
well as high capacity utilisation. The bottom line is that the good
quarterly result was driven less by market growth than by the
implementation of strategic measures", CEO Fahnemann adds.

Semperit continued to boast a sound capital base at the reporting
date of March 31, 2014. The equity ratio remained at the high level
of 49.0% compared to 48.3% at the end of 2013. Cash and cash
equivalents rose from EUR 182.6 million at year-end 2013 to EUR 188.1
million due to the strong operating cash flow generation. "Semperit
has operated successfully, and we are a sound footing financially. We
are more or less debt-free thanks to our strong cash position, and
still have a positive net liquidity of EUR 51.4 million after
deducting the financing liabilities. As a consequence, the financing
of future growth activities is secured", explains Semperit CFO
Johannes Schmidt-Schultes.

Medical Sector: Substantial revenue and earnings increases In the
Medical Sector (the Sempermed segment), the intensified sales
activities resulted in a considerable rise in sales volumes.
Therefore, the ongoing negative price effects caused by the lower raw
material prices were more than offset. Demand for examination gloves
in Europe and Asia was good. In particular, sales showed a
particularly positive development in the industrial and consumer
goods sectors. The capacity at the Sempermed production plants was
well utilised as in previous quarterly periods.

Revenue of the Medical Sector rose 6.9% in the first quarter of 2014
to EUR 114.1 million. EBITDA was up 28.9% to EUR 15.8 million,
providing an improved EBITDA margin of 13.8% compared to 11.5% in the
prior year.

Industrial Sector: Further increase in profitability The Industrial
Sector (the Semperflex, Sempertrans and Semperform segments)
generated further revenue and earnings growth. All three segments
further increased sales volumes, which can be mainly attributed to
the expansion of sales activities and the high acceptance of new
products on the part of customers. This served as the basis for
opening up new markets and gaining market shares.

In the Semperflex segment, sales successes and a very good capacity utilisation
of production plants led to substantial revenue and earnings growth. The
hydraulic hose business in Europe developed very well, whereas momentum picked
up in the American market. Demand for industrial hoses in most European markets
was very satisfactory, and the globalisation drive showed further success. The
Sempertrans segment achieved volume growth, especially for higher-priced product
groups. High demand in Europe, South America and Africa resulted in the full
capacity utilisation of its European production plants. However, negative raw
material price effects led to a decline in revenue and earnings. The Semperform
segment generated double-digit volume growth by gaining market shares.

Revenue of the Industrial Sector rose 9.4% in the first quarter of 2014 to EUR
118.6 million. EBITDA was up 14.4% to EUR 23.2 million, corresponding to an
excellent EBITDA margin of 19.6% compared to 18.7% in the prior-year quarter.
Double-digit EBIT margins were achieved in all three segments.

Outlook 2014 and multi-year targets

The Semperit Group expects a continuation of the current good level
of incoming orders for the rest of 2014 as well as a satisfactory
development of revenue and earnings compared to 2013. The Industrial
Sector is currently profiting from good demand in all segments. The
Medical Sector should continue on its dynamic growth path which is
not tied to overall economic growth.

The focus of the Sempermed segment will be on further enhancing the
efficiency of the individual production plants and the overall
profitability of the segment. The Semperit Group assumes that global
demand for examination and protective gloves will continue to rise.

A stable development is expected in the Industrial Sector in 2014 due
to the fact that production capacities are already being very well
utilised in all three segments. The expansion of capacities for
hydraulic and industrial hoses in Odry, Czech Republic and conveyor
belts at the Belchatów site in Poland is proceeding on schedule. The
additional production capacities will first be available in the first
half of 2015.

Semperit plans to invest about EUR 50-60 million to boost production
capacities and maintain its existing facilities.

The Semperit Group reaffirms its previous growth targets of
generating double-digit revenue growth on average in the years from
2010 to 2015. The Semperit Group still aims to achieve an EBITDA
margin ranging between 12% and 15% and an EBIT margin of between 8%
and 11% in the coming years.

The report on the first quarter of 2014 is available for download at
{http://www.semperitgroup.com/en/ir/publications/quarterly-reports/}[
HYPERLINK:
http://www.semperitgroup.com/en/ir/publications/quarterly-reports/]

About Semperit The publicly listed company Semperit AG Holding is an
internationally-oriented group that develops, produces, and sells in
more than 100 countries highly specialised rubber and plastic
products for the medical and industrial sectors: examination and
surgical gloves, hydraulic and industrial hoses, conveyor belts,
escalator handrails, construction profiles, cable car rings, and
products for railway superstructures. The headquarters of this
long-standing Austrian company, which was founded in 1824, are
located in Vienna, and the global R & D centre is in Wimpassing,
Lower Austria. The Semperit Group employs about 10,800 people
worldwide, including more than 7,000 in Asia and more than 700 in
Austria (Vienna and production site in Wimpassing, Lower Austria).
The Group has 22 manufacturing facilities worldwide and numerous
sales offices in Europe, Asia, and America. In 2013 the group
generated sales of EUR 906 million and an EBITDA of EUR 133 million.

Pictures with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/9MBuFHQS
http://resources.euroadhoc.com/us/iVsYiznE

Further inquiry note:
Martina Büchele
Head of Group Communications
Tel.: +43 676 8715 8621
martina.buechele@semperitgroup.com
www.semperitgroup.com

Stefan Marin
Investor Relations
Tel.: +43 676 8715 8210
stefan.marin@semperitgroup.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

Pictures with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/9MBuFHQS
http://resources.euroadhoc.com/us/iVsYiznE

issuer: Semperit AG Holding
Modecenterstrasse 22
A-1030 Wien
phone: +43 1 79 777-210
FAX: +43 1 79 777-602
mail: investor@semperitgroup.com
WWW: www.semperitgroup.com
sector: Synthetics & Plastics
ISIN: AT0000785555
indexes: WBI, ATX Prime, ViDX, Prime Market, ATX Global Players
stockmarkets: official market: Wien
language: English